VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome

Mise à jour : Il y a 4 ans
Référence : NCT01130246

Femme et Homme

Extrait

The objective of this study is to evaluate the safety and efficacy of short-term A-002 treatment on morbidity and mortality when added to atorvastatin and standard of care in subjects with an acute coronary syndrome (ACS).


Critère d'inclusion

  • Acute coronary syndrome


Liens